Literature DB >> 9722541

Association of protein kinase Cmu with type II phosphatidylinositol 4-kinase and type I phosphatidylinositol-4-phosphate 5-kinase.

K Nishikawa1, A Toker, K Wong, P A Marignani, F J Johannes, L C Cantley.   

Abstract

Protein kinase Cmu (PKCmu), also named protein kinase D, is an unusual member of the PKC family that has a putative transmembrane domain and pleckstrin homology domain. This enzyme has a substrate specificity distinct from other PKC isoforms (Nishikawa, K., Toker, A., Johannes, F. J., Songyang, Z., and Cantley, L. C. (1997) J. Biol. Chem. 272, 952-960), and its mechanism of regulation is not yet clear. Here we show that PKCmu forms a complex in vivo with a phosphatidylinositol 4-kinase and a phosphatidylinositol-4-phosphate 5-kinase. A region of PKCmu between the amino-terminal transmembrane domain and the pleckstrin homology domain is shown to be involved in the association with the lipid kinases. Interestingly, a kinase-dead point mutant of PKCmu failed to associate with either lipid kinase activity, indicating that autophosphorylation may be required to expose the lipid kinase interaction domain. Furthermore, the subcellular distribution of the PKCmu-associated lipid kinases to the particulate fraction depends on the presence of the amino-terminal region of PKCmu including the predicted transmembrane region. These results suggest a novel model in which the non-catalytic region of PKCmu acts as a scaffold for assembly of enzymes involved in phosphoinositide synthesis at specific membrane locations.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9722541     DOI: 10.1074/jbc.273.36.23126

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

1.  Specific interactions among transmembrane 4 superfamily (TM4SF) proteins and phosphoinositide 4-kinase.

Authors:  R L Yauch; M E Hemler
Journal:  Biochem J       Date:  2000-11-01       Impact factor: 3.857

2.  Regulation of type II PIP kinase by PKD phosphorylation.

Authors:  Katherine A Hinchliffe; Robin F Irvine
Journal:  Cell Signal       Date:  2006-03-06       Impact factor: 4.315

Review 3.  PKD regulates membrane fission to generate TGN to cell surface transport carriers.

Authors:  Vivek Malhotra; Felix Campelo
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-02-01       Impact factor: 10.005

4.  Type IIalpha phosphatidylinositol phosphate kinase associates with the plasma membrane via interaction with type I isoforms.

Authors:  Katherine A Hinchliffe; Maria Luisa Giudici; Andrew J Letcher; Robin F Irvine
Journal:  Biochem J       Date:  2002-05-01       Impact factor: 3.857

Review 5.  PIP kinases define PI4,5P₂signaling specificity by association with effectors.

Authors:  Suyong Choi; Narendra Thapa; Xiaojun Tan; Andrew C Hedman; Richard A Anderson
Journal:  Biochim Biophys Acta       Date:  2015-01-21

6.  P2X7 receptors activate protein kinase D and p42/p44 mitogen-activated protein kinase (MAPK) downstream of protein kinase C.

Authors:  Michelle D Bradford; Stephen P Soltoff
Journal:  Biochem J       Date:  2002-09-15       Impact factor: 3.857

7.  Delta protein kinase C interacts with the d subunit of the F1F0 ATPase in neonatal cardiac myocytes exposed to hypoxia or phorbol ester. Implications for F1F0 ATPase regulation.

Authors:  Tiffany Nguyen; Mourad Ogbi; John A Johnson
Journal:  J Biol Chem       Date:  2008-08-25       Impact factor: 5.157

8.  Protein kinase D1 autophosphorylation via distinct mechanisms at Ser744/Ser748 and Ser916.

Authors:  Vitalyi O Rybin; Jianfen Guo; Susan F Steinberg
Journal:  J Biol Chem       Date:  2008-11-24       Impact factor: 5.157

9.  Characterization of EVL-I as a protein kinase D substrate.

Authors:  Katrien Janssens; Line De Kimpe; Michele Balsamo; Sandy Vandoninck; Jackie R Vandenheede; Frank Gertler; Johan Van Lint
Journal:  Cell Signal       Date:  2008-10-29       Impact factor: 4.315

10.  Recruitment of protein kinase D to the trans-Golgi network via the first cysteine-rich domain.

Authors:  Y Maeda; G V Beznoussenko; J Van Lint; A A Mironov; V Malhotra
Journal:  EMBO J       Date:  2001-11-01       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.